期刊文献+

重组抑肽酶的生产工艺研究 被引量:2

Production process of recombinant aprotinin
下载PDF
导出
摘要 目的:优化融合表达抑肽酶基因工程菌的发酵条件,分离纯化抑肽酶。方法:设计3因素3水平的正交实验,考查玉米粉浓度、诱导时间和诱导剂乳糖浓度对菌体生长及蛋白表达的影响;在30 L发酵罐中进行中试放大试验;菌体经超声破壁和离心得到融合蛋白包涵体,经Bio-gel P30凝胶过滤纯化复性,用FXa切割,回收目的蛋白,最后用Resource RPC进行纯度验证。结果:融合蛋白的表达量为45%,包涵体复性率为70%以上,抑肽酶纯度为90%,总收率为32%,比活力为3.1 EPU/mg。结论:实现了含抑肽酶融合蛋白的较高表达,复性率及纯度达到较高水平,活力与天然产物相当。 Aim: To optimize the fermentation conditions of engineering bacteria expressing fusion proteins composed of aprotinin and to purify aprotinin. Methods: Orthogonal design was used to examine the influences of corn powder concentration, inducing time and the concentration of lactose as an inductor on the growth of cells and the expression level. 30 L fermentor was applied to carry out the scale-up production. Cells were collected by centrifugation and broke through by ultrasound. After renaturation and purification by Bio-gel P30, the fusion protein was then specifically digested with FXa and the recombinant aprotinin was obtained, which was confirmed to have the same characteristics as native aprotinin. Its purity was further analyzed by Resource RPC. Results:The fusion protein level, renaturation of inclusion bodies, purity of aprotinin, total recovery and the activity were about 45%, 70%, 90%, 32% and 3.1 EPU/mg respectively. Conclusion: High level expression of the fusion protein composed of aprotinin was achieved with satisfactory renaturation rate and purity and the equivalent activity with the natural aprotinin was obtained.
作者 董剑 吴梧桐
出处 《中国药科大学学报》 CAS CSCD 北大核心 2006年第4期375-378,共4页 Journal of China Pharmaceutical University
关键词 抑肽酶 凝血因子FXa 融合蛋白 复性 aprotinin factor Xa fusion protein renaturation
  • 相关文献

参考文献9

  • 1Ascenzi P, Bocedi A, Bolognesi M, et al. The bovine basic pancreatic trypsin inhibitor (Kunitz inhibitor): a milestone protein [J]. Curr Protein Pept Sci , 2003,4(3):231 -251.
  • 2Sylvie R, Bertil K. Aprotinin[J]. Ann Pharmacother, 1996,30(4):372 - 376.
  • 3Conni L, Poul E. BPTI and N-terminal extended analogues generated by factor Xa cleavage and cathepsin C trimming of a fusion protein in expressed in E. coli[J]. Protein Expr Purif, 1991,2(5 - 6) :372 -378.
  • 4Bjom N, Cara B. Secretion incompetence of bovine pancreatic trypsin inhabitor expression in E. coli [J]. J Biol Chem, 1995,266(5):2 970.
  • 5Gu ZY, Marianne Weidenhaupt. Chromatographic methods for the isolation and refolding of proteins from E. coli inclusion bodies[J].Protein Expr Purif, 2002,25 ( 1 ) : 174 - 179.
  • 6姚佳,杨坤,杨建波,华子春,杨洁.新型重组纤维蛋白原受体拮抗剂的表达、纯化及活性研究[J].中国药科大学学报,2005,36(2):173-178. 被引量:3
  • 7王淼,谭树华,吴梧桐.抑肽酶基因的克隆和表达[J].药物生物技术,2004,11(2):71-75. 被引量:6
  • 8国家药典委员会.中华人民共和国药典:二部[M].北京:化学工业出版社,1995:215—216.
  • 9Richard J,Jenny A,Kenneth G. A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa[J]. Protein Expr Putif,2003,31(1) : 1 - 11.

二级参考文献20

  • 1Sylvie R, Bertil K. The Annals of pharmacotherapy[J].Aprotinin, 1996, 30: 372.
  • 2Marks C. Mutant of bovine trypsin inhibitor lacking cystenes 14 and 38 can fold properly[J]. Science, 1987, 235:1370.
  • 3Cara B, Marks V, perter N, et al. Production of native,correctly folded bovine pancreatic trypsin inhibitor by E. coli[J]. JBC, 1986,261(16):7115.
  • 4Conni L, Poul E. BPTI and N-Terminal Extended Analougues Generated by Factor Xa Cleavage and Cathepsin C trimming of a Fusion Protein in Expressed in E. coli[J].Protein Expression and Purification, 1991,2 : 872.
  • 5Bjorn N, Cara B. Secretion incompetence of bovine pancreatic trypsin inhabitor expression in E. coli [J]. JBC, 1995,266(5):2970.
  • 6Ji Q, James R, George G. Expression of active human tissuctype plas-minogen Activator in Escherichia coli [J]. Applied and Envirmental Microbiology, 1998, 64( 12 ) : 48911.
  • 7Darby N J, Creighton T E. Dissecting the disulphide-coupled folding pathway of bovine pancreatic trypsin inhibitor.Forming the first disulphide bonds in analogues of the reduced protein[J]. Mol Biol, 1993,232(3) : 873.
  • 8吴双顶 赵超 刘清亮.一种高效提取活化的凝血因子X(FXa)的方法[P].中国发明专利公报 CN1297896A.2001.
  • 9Perumal T, Jonathan FT.Binding of Annexin V/placental anticoagulant protein I to platelets:evidence for phosphotidylserine exposure in the procoagulant response of activated platelets[J].J Biol Chem,1990,29:17 420 -17 423.
  • 10Murray CJ, Lopez AD.The global burden of disease:a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020 [J].Cambridge Harvard University Press,1996,17:176 -178.

共引文献8

同被引文献14

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部